Literature DB >> 15501375

Behavioral contingencies improve counseling attendance in an adaptive treatment model.

Robert K Brooner1, Michael S Kidorf, Van L King, Kenneth B Stoller, Jessica M Peirce, George E Bigelow, Ken Kolodner.   

Abstract

Poor patient adherence remains a serious obstacle to improving the effectiveness of many drug abuse therapies and the overall quality of care delivered in programs. The present study evaluated the utility and efficacy of incorporating behavioral contingencies in a stepped care treatment approach to motivate patient attendance to the varying amounts of prescribed weekly counseling. Study participants were opioid-dependent patients (n = 127) newly admitted to an ambulatory treatment program that provides methadone. Participants were randomly assigned to a Motivated Stepped Care condition (MSC; n = 65) with behavioral contingencies to specifically motivate counseling attendance vs. a Standard Stepped Care condition (SSC; n = 62) without these contingencies. The MSC vs. SSC condition was associated with a higher rate of counseling attendance (83% vs. 44%, p < .001) and a lower rate of poor treatment response (46% vs. 79%, p < .001). The behavioral contingencies were well tolerated and strongly associated with excellent attendance across both lower and higher doses of weekly counseling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15501375     DOI: 10.1016/j.jsat.2004.07.005

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  29 in total

1.  Disseminating contingency management to increase attendance in two community substance abuse treatment centers: lessons learned.

Authors:  Robrina Walker; Traci Rosvall; Craig A Field; Sean Allen; Daniel McDonald; Zeba Salim; Natalie Ridley; Bryon Adinoff
Journal:  J Subst Abuse Treat       Date:  2010-07-03

2.  Comparing adaptive stepped care and monetary-based voucher interventions for opioid dependence.

Authors:  Robert K Brooner; Michael S Kidorf; Van L King; Kenneth B Stoller; Karin J Neufeld; Ken Kolodner
Journal:  Drug Alcohol Depend       Date:  2007-01-24       Impact factor: 4.492

3.  Developing and testing adaptive treatment strategies using substance-induced psychosis as an example.

Authors:  Ree Dawson; Alan I Green; Robert E Drake; Thomas H McGlashan; Bella Schanzer; Philip W Lavori
Journal:  Psychopharmacol Bull       Date:  2008

4.  Adaptive Interventions in Drug Court: A Pilot Experiment.

Authors:  Douglas B Marlowe; David S Festinger; Patricia L Arabia; Karen L Dugosh; Kathleen M Benasutti; Jason R Croft; James R McKay
Journal:  Crim Justice Rev       Date:  2008

5.  Innovative Clinical Trial Designs: Toward a 21st-Century Health Care System.

Authors:  Tze L Lai; Philip W Lavori
Journal:  Stat Biosci       Date:  2011-12

6.  Effect of a stepped-care intervention approach on weight loss in adults: a randomized clinical trial.

Authors:  John M Jakicic; Deborah F Tate; Wei Lang; Kelli K Davis; Kristen Polzien; Amy D Rickman; Karen Erickson; Rebecca H Neiberg; Eric A Finkelstein
Journal:  JAMA       Date:  2012-06-27       Impact factor: 56.272

7.  Is level of exposure to a 12-step facilitation therapy associated with treatment outcome?

Authors:  Elizabeth A Wells; Dennis M Donovan; Dennis C Daley; Suzanne R Doyle; Greg Brigham; Sharon B Garrett; Michelle H Ingalsbe; Mary A Hatch-Maillette; Harold I Perl; Robrina Walker
Journal:  J Subst Abuse Treat       Date:  2014-06-14

Review 8.  The Role of Behavioral Interventions in Buprenorphine Maintenance Treatment: A Review.

Authors:  Kathleen M Carroll; Roger D Weiss
Journal:  Am J Psychiatry       Date:  2016-12-16       Impact factor: 18.112

9.  A behavioral treatment for opioid-dependent patients with antisocial personality.

Authors:  Karin J Neufeld; Michael S Kidorf; Kenneth Kolodner; Van L King; Michael Clark; Robert K Brooner
Journal:  J Subst Abuse Treat       Date:  2007-06-15

10.  Effect of traumatic event reexposure and PTSD on substance use disorder treatment response.

Authors:  Jessica M Peirce; Robert K Brooner; Van L King; Michael S Kidorf
Journal:  Drug Alcohol Depend       Date:  2015-11-21       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.